Benzonatate Capsule
Product Images NDC 71335-2790

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 71335-2790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Forluma For Benzonatate (52dc3ff3 F01b 4820 Ba1e B043a5b2c49a 01)

FDA Label Image

Label (Lbl713352790)

Label (Lbl713352790)
Each soft gelatin capsule contains Benzonatate, USP 200 mg. This medication should be stored at 20° to 25°C (68° to 77°F) and protected from light. The capsules are intended to be swallowed whole and should not be broken, chewed, dissolved, cut, or crushed. For more detailed information, refer to the package insert and scan the QR code for complete prescribing details. The product is dispensed in a container that meets the USP standards. This information is essential for patients taking Benzonatate capsules.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.